CSTL vs XLI
Castle Biosciences Inc (CSTL) versus XLI (XLI) — a side-by-side from cached financials, not a winner call.
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
XLI (XLI) common stock.
Latest reported CSTL revenue for 2026-06-30 was $187.2M. Net income was -$16.6M. CSTL currently screens at market cap $570.2M.
XLI does not have a complete income-statement cache yet.
CSTL currently screens at market cap $570.2M. XLI currently screens at market cap $0.
Not investment advice. Open the CSTL and XLI stock pages for the full models.
Not investment advice.